European Healthtech startup funding raised during H1 2015.
In H1 2015, 85 European Healthtech companies raised a combined €505M across 91 funding rounds, up 47.4% versus H1 2014. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
8 exits · €295M disclosed.
| Dezima Pharma | Acquisition | Feb 2015 | €273M |
| AMO Pharma | Buyout | May 2015 | €23M |
| €34M |
| GenSight Biologics | Series B | Jun 2015 | €32M |
| Echosens | Growth/Late | Mar 2015 | €31M |
| Advanced Accelerator Applications | Growth/Late | May 2015 | €23M |
| InSphero | Series C | Jun 2015 | €18M |
| Allecra Therapeutics | Series A | Mar 2015 | €15M |
| BONESUPPORT | Growth/Late | Mar 2015 | €13M |
| MST - Medical Surgery Technologies | Series C | Jun 2015 | €11M |
| TytoCare | Series B | Jun 2015 | €10M |
| Onbone | Early VC | Mar 2015 | €10M |
| Vittamed | Other | Mar 2015 | €9.3M |
| docplanner | Series B | Apr 2015 | €8.9M |
